IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 193 filers reported holding IMMUNOGEN INC in Q1 2023. The put-call ratio across all filers is 0.37 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,935,000 | +84001.7% | 500,000 | 0.0% | 8.42% | -8.5% |
| Q2 2023 | $9,435 | +391.4% | 500,000 | 0.0% | 9.20% | +303.6% |
| Q1 2023 | $1,920 | -22.6% | 500,000 | 0.0% | 2.28% | -23.0% |
| Q4 2022 | $2,480 | -99.9% | 500,000 | 0.0% | 2.96% | +11.0% |
| Q3 2022 | $2,390,000 | +11.8% | 500,000 | +5.3% | 2.67% | +17.3% |
| Q2 2022 | $2,138,000 | -0.2% | 475,000 | +5.6% | 2.28% | +26.5% |
| Q1 2022 | $2,142,000 | -23.0% | 450,000 | +20.0% | 1.80% | -14.5% |
| Q4 2021 | $2,783,000 | +30.9% | 375,000 | 0.0% | 2.10% | +32.5% |
| Q3 2021 | $2,126,000 | -14.0% | 375,000 | 0.0% | 1.59% | -11.2% |
| Q2 2021 | $2,471,000 | -18.7% | 375,000 | 0.0% | 1.79% | -20.9% |
| Q1 2021 | $3,038,000 | +25.6% | 375,000 | 0.0% | 2.26% | +0.7% |
| Q4 2020 | $2,419,000 | – | 375,000 | – | 2.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 600,000 | $3,870,000 | 2.25% |
| CM Management, LLC | 375,000 | $2,419,000 | 2.24% |
| Consonance Capital Management LP | 3,515,944 | $22,678,000 | 2.12% |
| RA Capital Management | 18,417,458 | $118,793,000 | 1.66% |
| Kercheville Advisors, LLC | 244,421 | $1,564,000 | 0.85% |
| Redmile Group, LLC | 10,528,179 | $67,907,000 | 0.82% |
| Birchview Capital, LP | 190,000 | $1,226,000 | 0.71% |
| QVT Financial LP | 1,375,900 | $8,875,000 | 0.49% |
| Fernwood Investment Management, LLC | 149,340 | $963,000 | 0.38% |
| TWIN FOCUS CAPITAL PARTNERS, LLC | 104,068 | $671,000 | 0.21% |